North America diabetic assays market is projected to register a substantial in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
By Type (Assays, Devices, Consumables), Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), Deployment (Automated, Manual), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic Institutes, Others), Distribution Channel (Direct, Indirect), Country (U.S., Canada, Mexico)

Some of the major factors contributing to the growth of the market are:
- Growing technology advancement of the market
- Rising research and developments activities

Market Players:

The key market players for North America diabetic assays market are listed below:

- Abbott
- Danaher
- Merck KGaA
- SIEMENS HEALTHINEERS AG
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- EKF Diagnostics
- DRG INSTRUMENTS GMBH
- PTS Diagnostics
- Ortho Clinical Diagnostics
- Medipan GmbH
- Diagnostic Automation/Cortez Diagnostics Inc.
- Diazyme Laboratories, Inc.
- Ethos Biosciences, Inc.
- BioAssay Systems
- Tosoh Corporation
- Abnova Corporation
- Monobind Inc
- ORGENTEC Diagnostika GmbH
- ALPCO